How using brain-machine interfaces influences the human sense of agency.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 30 03 2020
accepted: 23 12 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 11 5 2021
Statut: epublish

Résumé

Brain-machine interfaces (BMI) allows individuals to control an external device by controlling their own brain activity, without requiring bodily or muscle movements. Performing voluntary movements is associated with the experience of agency ("sense of agency") over those movements and their outcomes. When people voluntarily control a BMI, they should likewise experience a sense of agency. However, using a BMI to act presents several differences compared to normal movements. In particular, BMIs lack sensorimotor feedback, afford lower controllability and are associated with increased cognitive fatigue. Here, we explored how these different factors influence the sense of agency across two studies in which participants learned to control a robotic hand through motor imagery decoded online through electroencephalography. We observed that the lack of sensorimotor information when using a BMI did not appear to influence the sense of agency. We further observed that experiencing lower control over the BMI reduced the sense of agency. Finally, we observed that the better participants controlled the BMI, the greater was the appropriation of the robotic hand, as measured by body-ownership and agency scores. Results are discussed based on existing theories on the sense of agency in light of the importance of BMI technology for patients using prosthetic limbs.

Identifiants

pubmed: 33411838
doi: 10.1371/journal.pone.0245191
pii: PONE-D-20-06849
pmc: PMC7790430
doi:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0245191

Déclaration de conflit d'intérêts

The authors declared that they had no conflicts of interest with respect to their authorship or the publication of this article.

Références

Electroencephalogr Clin Neurophysiol. 1959 Aug;11(3):497-510
pubmed: 13663823
Trends Neurosci. 1997 Jan;20(1):44-9
pubmed: 9004419
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:6607-10
pubmed: 24111257
Conscious Cogn. 2012 Mar;21(1):546-61
pubmed: 22240158
Front Hum Neurosci. 2012 Mar 14;6:40
pubmed: 22435056
Nat Neurosci. 2002 Apr;5(4):382-5
pubmed: 11896397
Nature. 1998 Feb 19;391(6669):756
pubmed: 9486643
Cognition. 2016 Dec;157:114-125
pubmed: 27610746
Neurosci Lett. 1997 Dec 19;239(2-3):65-8
pubmed: 9469657
Front Psychol. 2016 Aug 03;7:1165
pubmed: 27536267
Cognition. 2008 Jun;107(3):978-98
pubmed: 18262508
Conscious Cogn. 2014 May;26:117-32
pubmed: 24705182
Front Hum Neurosci. 2014 Aug 21;8:643
pubmed: 25191256
Brain Res Cogn Brain Res. 2005 Dec;25(3):668-77
pubmed: 16236487
Neuropsychologia. 1998 Nov;36(11):1133-40
pubmed: 9842759
Trends Neurosci. 2006 Sep;29(9):536-46
pubmed: 16859758
IEEE Trans Neural Syst Rehabil Eng. 2005 Mar;13(1):89-98
pubmed: 15813410
Comput Intell Neurosci. 2011;2011:156869
pubmed: 21253357
Trends Cogn Sci. 2000 Jan;4(1):14-21
pubmed: 10637618
Perception. 2009;38(2):271-80
pubmed: 19400435
Conscious Cogn. 2008 Mar;17(1):219-39
pubmed: 17482480
Front Psychol. 2016 Aug 29;7:1272
pubmed: 27621713
Nat Rev Neurosci. 2017 Apr;18(4):196-207
pubmed: 28251993
PLoS One. 2015 Jun 12;10(6):e0130019
pubmed: 26066840
Brain Topogr. 2010 Jun;23(2):194-8
pubmed: 19946737
Brain Cogn. 2017 Feb;111:44-50
pubmed: 27816779
J Neural Eng. 2013 Oct;10(5):056014
pubmed: 23985960
Conscious Cogn. 2012 Mar;21(1):59-68
pubmed: 21920777
Conscious Cogn. 2013 Dec;22(4):1431-41
pubmed: 24161792
J Physiol. 2007 Mar 15;579(Pt 3):613-9
pubmed: 17255164
Conscious Cogn. 2015 May;33:226-36
pubmed: 25655206
Neuroreport. 2000 Aug 3;11(11):R11-6
pubmed: 10943682
Brain Res Brain Res Rev. 2005 Dec 1;50(1):57-68
pubmed: 15925412
Conscious Cogn. 2009 Dec;18(4):1056-64
pubmed: 19515577
Behav Res Methods. 2015 Sep;47(3):744-55
pubmed: 24942249
Cognition. 2013 Dec;129(3):574-8
pubmed: 24060604
Clin Neurophysiol. 2000 Oct;111(10):1873-9
pubmed: 11018505
Neuroimage. 2015 Jan 1;104:59-68
pubmed: 25315784

Auteurs

Emilie A Caspar (EA)

CO3 lab, Center for Research in Cognition and Neuroscience, Université libre de Bruxelles, Brussels, Belgium.

Albert De Beir (A)

Vrij Universiteit Brussels, Brussels, Belgium.
Flanders Make, Lommel, Belgium.

Gil Lauwers (G)

Vrij Universiteit Brussels, Brussels, Belgium.

Axel Cleeremans (A)

CO3 lab, Center for Research in Cognition and Neuroscience, Université libre de Bruxelles, Brussels, Belgium.

Bram Vanderborght (B)

Vrij Universiteit Brussels, Brussels, Belgium.
Flanders Make, Lommel, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH